Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink

Mahmoudpour Seyed Hamidreza; Baranova Ekaterina Vitalievna; Souverein Patrick C.; Asselbergs Folkert W.; de Boer Anthonius; Maitland-van der Zee Anke Hilse

首页> 外文期刊>British Journal of Clinical Pharmacology >Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink

【24h】

Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink

机译：英国临床实践研究数据链中血管紧张素转换酶抑制剂（ACEI）不耐受和血管性水肿的决定因素

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimThe aim of the present study was to describe the occurrence and determinants of angiotensin-converting enzyme (ACE) inhibitor (ACEI) intolerance and angioedema (AE) among patients initiating ACEI therapy in a real-world primary care population.

机译：目的本研究的目的是描述在现实世界的初级保健人群中开始ACEI治疗的患者中血管紧张素转换酶（ACE）抑制剂（ACEI）耐受性和血管性水肿（AE）的发生及其影响因素。

著录项

来源
《British Journal of Clinical Pharmacology》 |2016年第6期|共13页
作者
Mahmoudpour Seyed Hamidreza; Baranova Ekaterina Vitalievna; Souverein Patrick C.; Asselbergs Folkert W.; de Boer Anthonius; Maitland-van der Zee Anke Hilse;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
ACE inhibitors; ACE inhibitor intolerance; angioedema; angiotensin II receptor blockers; case-control studies; drug-related side effects and adverse reactions;

机译：ACE抑制剂;ACE抑制剂不耐受;血管性水肿;血管紧张素II受体阻滞剂;病例对照研究;药物相关的副作用和不良反应;
入库时间 2022-08-18 09:14:12

相似文献

外文文献
中文文献
专利

1. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink [J] . Mahmoudpour Seyed Hamidreza, Baranova Ekaterina Vitalievna, Souverein Patrick C., British Journal of Clinical Pharmacology . 2016,第6期

机译：英国临床实践研究数据链中血管紧张素转换酶抑制剂（ACEI）不耐受和血管性水肿的决定因素
2. ASSOCIATIONS OF COMORBIDITIES AND CO-MEDICATIONS WITH ANGIOEDEMA DURING THE USE OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS WITHIN THE UNITED KINGDOM CLINICAL PRACTICE RESEARCH DATALINK [J] . Mahmoudpour S. H., Baranova E. V, Souverein P. C., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第3期

机译：联合王国临床实践研究中使用血管紧张素转换酶抑制剂的过程中与血管紧张素联合症的联合和联合治疗
3. Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria [J] . Nicola Bonner, Charlotte Panter, Alan Kimura, BMC Health Services Research . 2017,第1期

机译：血管紧张素转化酶抑制剂（ACEI）诱导血管模型调查仪评级规模和提出的出院标准的开发和验证
4. The Prevalence of Potential Clinically Significant Drug Interactions with Angiotensin-Converting Enzyme Inhibitors in Slovenia [C] . Marjetka P., Brane L, Polonca F. European Congress of Pharmacology . 2012

机译：斯洛文尼亚血管紧张素转化酶抑制剂潜在临床显着的药物相互作用的患病率
5. PHOSPHONAMIDATE PEPTIDE ANALOGUES AS INHIBITORS OF ENKEPHALINASE AND ANGIOTENSIN-CONVERTING ENZYME (TRANSITION-STATE INHIBITORS, METALLOENDOPEPTIDASE). [D] . ELLIOTT, RICHARD LOUIS. 1984

机译：膦酰胺肽类似物作为脑啡肽酶和血管紧张素转化酶的抑制剂（过渡态抑制剂，金属内肽酶）。
6. Determinants of angiotensin‐converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink [O] . Seyed Hamidreza Mahmoudpour, Ekaterina Vitalievna Baranova, Patrick C. Souverein, 2016

机译：英国临床实践研究数据链中血管紧张素转换酶抑制剂（ACEI）不耐受和血管水肿的决定因素
7. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink [O] . Mahmoudpour, Seyed Hamidreza, Baranova, Ekaterina Vitalievna, Souverein, Patrick C., 2016

机译：英国临床实践研究数据链中血管紧张素转换酶抑制剂（ACEI）不耐受和血管性水肿的决定因素

Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink

摘要

著录项

相似文献

相关主题

期刊订阅